Literature DB >> 25245455

Reovirus FAST proteins: virus-encoded cellular fusogens.

Marta Ciechonska1, Roy Duncan2.   

Abstract

Reovirus fusion-associated small transmembrane (FAST) proteins are the only known nonenveloped virus fusogens and are dedicated to inducing cell-to-cell, not virus-cell, membrane fusion. Numerous structural and functional attributes distinguish this novel family of viral fusogens from all enveloped virus membrane fusion proteins. Both families of viral fusogens play key roles in virus dissemination and pathogenicity, but employ different mechanisms to mediate membrane apposition and merger. However, convergence of these distinct families of viral membrane fusion proteins on common pathways needed for pore expansion and syncytium formation suggests syncytiogenesis represents a cellular response to the presence of cell-cell fusion pores. Together, FAST proteins and enveloped virus fusion proteins provide exceptional insights into the ubiquitous process of cell-cell membrane fusion and syncytium formation.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  cell–cell fusion; syncytium formation; viral membrane fusion proteins

Mesh:

Substances:

Year:  2014        PMID: 25245455     DOI: 10.1016/j.tim.2014.08.005

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  33 in total

1.  The 13th International Double-Stranded RNA Virus Symposium, Houffalize, Belgium, 24 to 28 September 2018.

Authors:  Ulrich Desselberger
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

2.  Evolutionarily related small viral fusogens hijack distinct but modular actin nucleation pathways to drive cell-cell fusion.

Authors:  Ka Man Carmen Chan; Ashley L Arthur; Johannes Morstein; Meiyan Jin; Abrar Bhat; Dörte Schlesinger; Sungmin Son; Donté A Stevens; David G Drubin; Daniel A Fletcher
Journal:  Proc Natl Acad Sci U S A       Date:  2021-01-05       Impact factor: 11.205

3.  Reverse genetics of rotavirus.

Authors:  Ulrich Desselberger
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-09       Impact factor: 11.205

4.  Myomaker and Myomerger Work Independently to Control Distinct Steps of Membrane Remodeling during Myoblast Fusion.

Authors:  Evgenia Leikina; Dilani G Gamage; Vikram Prasad; Joanna Goykhberg; Michael Crowe; Jiajie Diao; Michael M Kozlov; Leonid V Chernomordik; Douglas P Millay
Journal:  Dev Cell       Date:  2018-09-06       Impact factor: 12.270

5.  Cell-surface phosphatidylserine regulates osteoclast precursor fusion.

Authors:  Santosh K Verma; Evgenia Leikina; Kamran Melikov; Claudia Gebert; Vardit Kram; Marian F Young; Berna Uygur; Leonid V Chernomordik
Journal:  J Biol Chem       Date:  2017-11-03       Impact factor: 5.157

6.  Fusogenic micropeptide Myomixer is essential for satellite cell fusion and muscle regeneration.

Authors:  Pengpeng Bi; John R McAnally; John M Shelton; Efrain Sánchez-Ortiz; Rhonda Bassel-Duby; Eric N Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2018-03-26       Impact factor: 11.205

Review 7.  Cell Fusion: Merging Membranes and Making Muscle.

Authors:  Michael J Petrany; Douglas P Millay
Journal:  Trends Cell Biol       Date:  2019-10-21       Impact factor: 20.808

8.  Entirely plasmid-based reverse genetics system for rotaviruses.

Authors:  Yuta Kanai; Satoshi Komoto; Takahiro Kawagishi; Ryotaro Nouda; Naoko Nagasawa; Misa Onishi; Yoshiharu Matsuura; Koki Taniguchi; Takeshi Kobayashi
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-30       Impact factor: 11.205

9.  Rotavirus Species B Encodes a Functional Fusion-Associated Small Transmembrane Protein.

Authors:  Julia R Diller; Helen M Parrington; John T Patton; Kristen M Ogden
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

Review 10.  Use of cell fusion proteins to enhance adenoviral vector efficacy as an anti-cancer therapeutic.

Authors:  Joshua Del Papa; Ryan G Clarkin; Robin J Parks
Journal:  Cancer Gene Ther       Date:  2020-07-01       Impact factor: 5.987

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.